Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Analgesic Efficacy of NVL vs LFCN Block After Knee Surgeries
NCT06809842Recruiting
- Sponsor
- Kafrelsheikh University
- Start
- Feb 2025
- Primary completion
- Jul 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised trial of bupivacaine in postoperative pain (2 arms), sponsored by Kafrelsheikh University. Primary endpoint: Degree of pain at 24 hours. Started Feb 2025; status: recruiting.
02
Drugs
bupivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT06809842.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06809842.